These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28622968)

  • 1. The beneficial effect of extracorporeal shockwave myocardial revascularization: Two years of follow-up.
    Alunni G; Barbero U; Vairo A; D'Amico S; Pianelli M; Zema D; Bongiovanni F; Gaita F
    Cardiovasc Revasc Med; 2017 Dec; 18(8):572-576. PubMed ID: 28622968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beneficial effect of extracorporeal shockwave myocardial revascularization in patients with refractory angina.
    Alunni G; Marra S; Meynet I; D'amico M; Elisa P; Fanelli A; Molinaro S; Garrone P; Deberardinis A; Campana M; Lerman A
    Cardiovasc Revasc Med; 2015; 16(1):6-11. PubMed ID: 25555620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of extracorporeal shock wave myocardial revascularization therapy for refractory angina pectoris.
    Cassar A; Prasad M; Rodriguez-Porcel M; Reeder GS; Karia D; DeMaria AN; Lerman A
    Mayo Clin Proc; 2014 Mar; 89(3):346-54. PubMed ID: 24582193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of extracorporeal shockwave myocardial revascularization on the ischemic burden of refractory angina patients: a single photon emission computed tomography study.
    Alunni G; D'''''Amico S; Castelli C; De Lio G; Fioravanti F; Gallone G; Marra S; De Ferrari GM
    Minerva Cardioangiol; 2020 Dec; 68(6):567-576. PubMed ID: 32319266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal shockwave myocardial revascularization improves clinical symptoms and left ventricular function in patients with refractory angina.
    Zuozienė G; Laucevičius A; Leibowitz D
    Coron Artery Dis; 2012 Jan; 23(1):62-7. PubMed ID: 22107803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and Safety of Extracorporeal Shockwave Myocardial Revascularization in Patients With Refractory Angina Pectoris and Heart Failure.
    Martínez-Sánchez C; Azar-Manzur F; González-Pacheco H; Amezcua-Guerra LM; Massó F; Márquez-Velasco R; Bojalil R; Carvajal-Juárez I; Alexanderson-Rosas E; Hernández S; Paez-Arenas A; López-Mora E; Venegas-Román A; Brianza-Padilla M; Gopar-Nieto R; Sandoval J
    Am J Cardiol; 2021 Apr; 144():26-32. PubMed ID: 33385348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal shockwave myocardial therapy is efficacious in improving symptoms in patients with refractory angina pectoris--a multicenter study.
    Prasad M; Wan Ahmad WA; Sukmawan R; Magsombol EB; Cassar A; Vinshtok Y; Ismail MD; Mahmood Zuhdi AS; Locnen SA; Jimenez R; Callleja H; Lerman A
    Coron Artery Dis; 2015 May; 26(3):194-200. PubMed ID: 25734606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of Extracorporeal Shock Wave Myocardial Revascularization Therapy for Post-Acute Myocardial Infarction Patients and Refractory Angina Pectoris Patients.
    Myojo M; Ando J; Uehara M; Daimon M; Watanabe M; Komuro I
    Int Heart J; 2017 Apr; 58(2):185-190. PubMed ID: 28320996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shock-Wave Therapy Improves Myocardial Blood Flow Reserve in Patients with Refractory Angina: Evaluation by Real-Time Myocardial Perfusion Echocardiography.
    Ceccon CL; Duque AS; Gowdak LH; Mathias W; Chiang HP; Sbano JCN; Lima MF; Machado Cesar LA; Cruz CBBV; Dourado PMM; Meneghetti C; Tsutsui JM
    J Am Soc Echocardiogr; 2019 Sep; 32(9):1075-1085. PubMed ID: 31235421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac shock wave therapy improves myocardial perfusion and preserves left ventricular mechanics in patients with refractory angina: A study with speckle tracking echocardiography.
    Duque AS; Ceccon CL; Mathias W; Majesky JD; Gowdak LH; Sbano JCN; Cesar LAM; Abduch MC; Lima MSM; Dourado PMM; Cruz CBBV; Tsutsui JM
    Echocardiography; 2018 Oct; 35(10):1564-1570. PubMed ID: 29962073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter trial of extracorporeal cardiac shock wave therapy for refractory angina pectoris: report of the highly advanced medical treatment in Japan.
    Kikuchi Y; Ito K; Shindo T; Hao K; Shiroto T; Matsumoto Y; Takahashi J; Matsubara T; Yamada A; Ozaki Y; Hiroe M; Misumi K; Ota H; Takanami K; Hiraide T; Takase K; Tanji F; Tomata Y; Tsuji I; Shimokawa H
    Heart Vessels; 2019 Jan; 34(1):104-113. PubMed ID: 29942978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal myocardial shockwave therapy; a precious blast for refractory angina patients.
    Slavich M; Pizzetti G; Vella AM; Carlucci C; Margonato D; Spoladore R; Fragasso G; Margonato A
    Cardiovasc Revasc Med; 2018 Apr; 19(3 Pt A):263-267. PubMed ID: 29122526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia.
    Beeres SL; Bax JJ; Dibbets P; Stokkel MP; Zeppenfeld K; Fibbe WE; van der Wall EE; Schalij MJ; Atsma DE
    J Nucl Med; 2006 Apr; 47(4):574-80. PubMed ID: 16595489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac shock wave therapy reduces angina and improves myocardial function in patients with refractory coronary artery disease.
    Wang Y; Guo T; Cai HY; Ma TK; Tao SM; Sun S; Chen MQ; Gu Y; Pang JH; Xiao JM; Yang XY; Yang C
    Clin Cardiol; 2010 Nov; 33(11):693-9. PubMed ID: 21089114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracoronary autologous CD34+ stem cell therapy for intractable angina.
    Wang S; Cui J; Peng W; Lu M
    Cardiology; 2010; 117(2):140-7. PubMed ID: 20975266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of extracorporeal shockwave myocardial revascularization therapy to myocardial perfusion and function in indicated CABG-stable angina pectoris patients: case series.
    Tiksnadi BB; Adiputro DL; Akbar MR; Soeriadi EA; Hasan M; Muttaqien F; Raharjo PP; Nurazizah E; Tarsidin NF
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):6959-6966. PubMed ID: 34859857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A first-in-man study of percutaneous myocardial cryotreatment in nonrevascularizable patients with refractory angina.
    Gallo R; Fefer P; Freeman M; Andrew P; Stewart DJ; Theroux P; Strauss BH
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):387-94. PubMed ID: 19496148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Percutaneous myocardial laser revascularization. A new therapy technique for patients with coronary disease and severe angina pectoris without conventional therapy options].
    Lauer B; Stahl F; Junghans U; Kluge R; Schuler G
    Dtsch Med Wochenschr; 2000 Mar; 125(13):377-82. PubMed ID: 10778398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study between the therapeutic effects of surgical myocardial revascularization and coronary angioplasty in equivalent ischemic situations: analysis through myocardial scintigraphy with 99mTc-Sestamibi].
    Moreira AE; Hueb WA; Soares PR; Meneghetti JC; Jorge MC; Chalela WA; Martinez Filho EE; Oliveira SA; Jatene FB; Ramires JA
    Arq Bras Cardiol; 2005 Aug; 85(2):92-9. PubMed ID: 16113846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Cardiac Shock Wave Therapy an Option for the Treatment of Myocardial Ischemia in Patients with Refractory Angina?
    Nudi F; Tomai F
    J Nucl Cardiol; 2022 Oct; 29(5):2420-2422. PubMed ID: 34755270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.